The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study.
Abstract
PURPOSE: The purpose of this study was to investigate the effect of acitretin on the development of keratotic skin lesions, and on squamous cell carcinomas and basal cell carcinomas in a group of renal transplant recipients. PATIENTS AND METHODS: Forty-four renal transplant recipients with more than 10 keratotic skin lesions on the hands and forearms were enrolled onto a randomized, double-blind, placebo-controlled trial to test the possible skin cancer-preventing effect of a 6-month treatment with acitretin 30 mg/d. RESULTS: No deterioration in renal function occurred in any of the 38 assessable patients treated. During the 6-month treatment period, two of 19 patients (11%) in the acitretin group reported a total of two new squamous cell carcinomas, compared with nine of 19 patients (47%) in the placebo group who developed a total of 18 new carcinomas (chi 2 = 6.27, P = .01). The relative decrease in the number of keratotic skin lesions in the acitretin group was 13.4%, as compared with a relative increase in the placebo group of 28.2% (difference, 41.6%; 95% confidence interval, 11.5 to 71.7). Most patients treated with acitretin had mild mucocutaneous side effects, but these were easily manageable. Some patients experienced mild hair loss. With the exception of three patients, no increase in serum cholesterol or triglyceride above pretreatment levels was observed, and liver function remained unchanged in all patients. CONCLUSION: Acitretin 30 mg/d over 6 months had significantly more effect than placebo in the prevention of squamous cell carcinomas and reduced the occurrence of keratotic skin lesions in a group of renal transplant recipients with severe lesions. This effect was most pronounced in patients with a history of squamous cell carcinomas and basal cell carcinomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hong, W. K., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R. M., Schantz, S. P., Kramer, A. M., Lotan, R., Peters, L. J., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009203231205 · Cited by 1,365
Prevention of Skin Cancer in Xeroderma Pigmentosum with the Use of Oral Isotretinoin
Kraemer, K. H., DiGiovanna, J. J., Moshell, A. N., Tarone, R. E., & Peck, G. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806233182501 · Cited by 575
Berkhout, R. J. M., Tieben, L. M., Smits, H. L., Bavinck, J. N. B., Vermeer, B. J., & ter Schegget, J. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.3.690-695.1995 · Cited by 336
Self-citationHUMAN PAPILLOMA VIRUS INFECTION AND SKIN CANCER IN RENAL ALLOGRAFT RECIPIENTS
Barr, B. B. B., Mclaren, K., Smith, I. W., Benton, E. C., Bunney, M. H., Blessing, K., & Hunter, J. A. A. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91143-4 · Cited by 307
CANCER, WARTS, AND SUNSHINE IN RENAL TRANSPLANT PATIENTS
Boyle, J., Briggs, J. D., Mackie, R., Junor, B. J. R., & Aitchison, T. C. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92221-9 · Cited by 295
Relation between Skin Cancer and HLA Antigens in Renal-Transplant Recipients
Bavinck, J. N. B., Vermeer, B. J., van der Woude, F. J., Vandenbroucke, J. P., Schreuder, G. M. T., Thorogood, J., Persijn, G. G., & Claas, F. H. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109193251203 · Cited by 180
Self-citationSunlight, keratotic skin lesions and skin cancer in renal transplant recipients
BAVINCK, J. N. B., BOER, A. D., VERMEER, B. J., HARTEVELT, M. M., WOUDE, F. J. V. D., CLAAS, F. H. J., WOLTERBEEK, R., & VANDENBROUCKE, J. P. (1993) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1993.tb11841.x · Cited by 172
Self-citationETRETINATE IN TREATMENT OF ACTINIC KERATOSIS
Moriarty, M. J., Dunn, J. A., Darragh, A., et al. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91393-9 · Cited by 135
Bartsch, D., Boye, B., Baust, C., Hausen, H. Z., & Schwarz, E. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05287.x · Cited by 121
Does cyclosporin increase lipoprotein(a) concentrations in renal transplant recipients?
Webb, A. T., Seed, M., Brown, E. A., Reaveley, D. A., O'Donnell, M., & O'Connor, B. (1993) · The Lancet · doi:10.1016/0140-6736(93)92616-2 · Cited by 78
Cited by
Skin cancers after organ transplantation
Euvrard, S., Kanitakis, J., & Claudy, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022137 · Cited by 1,575
Guidelines of care for the management of psoriasis and psoriatic arthritis
Gottlieb, A., Korman, N. J., Gordon, K. B., Feldman, S. R., Lebwohl, M., Koo, J. Y. M., Van Voorhees, A. S., Elmets, C. A., Leonardi, C. L., Beutner, K. R., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.02.040 · Cited by 769
A Phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention
Chen, A. C., Martin, A. J., Choy, B., Fernández-Peñas, P., Dalziell, R. A., McKenzie, C. A., Scolyer, R. A., Dhillon, H. M., Vardy, J. L., Kricker, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506197 · Cited by 648
Post-Transplant Malignancy: The Role Of Immunosuppression
Penn, I. (2000) · Drug Safety · doi:10.2165/00002018-200023020-00002 · Cited by 414
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01848-7 · Cited by 399
Metadata
- Authors
- Bavinck, J. N., Tieben, L. M., Van der Woude, F. J., Tegzess, A. M., Hermans, J., ter Schegget, J., & Vermeer, B. J.
- Venue
- Journal of Clinical Oncology
- Published
- 1995-08
- Volume
- 13
- Issue
- 8
- Pages
- 1933-1938
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1832821854
- Cited by
- 397
- References
- 14
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. https://app.cochat.ai/papers/10.1200/jco.1995.13.8.1933
- The paper
- Bavinck, J. N., Tieben, L. M., Van der Woude, F. J., Tegzess, A. M., Hermans, J., ter Schegget, J., & Vermeer, B. J. (1995). Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. Journal of Clinical Oncology. https://doi.org/10.1200/jco.1995.13.8.1933
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.